[1] |
中华医学会内分泌学分会. 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)[J]. 中华内分泌代谢杂志,2020,36(9):737-750.
|
[2] |
Lenders JW,Duh QY,Eisenhofer G,et al. Pheochromocytoma and paraganglioma: An Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2014, 99(6): 1915-1942.
|
[3] |
李赟,李娜,郭宁,等. 妊娠合并嗜铬细胞瘤/副神经节瘤5例临床特征及预后分析[J]. 中国综合临床,2022,38(1):24-29.
|
[4] |
Mohamed Ismail NA, Abd Rahman R, Abd Wahab N, et al. Pheochromocytoma and pregnancy: a difficult and dangerous ordeal[J]. Malays J Med Sci, 2012, 19(1): 65-68.
|
[5] |
Aygun N, Uludag M. Pheochromocytoma and paraganglioma: from clinical findings to diagnosis[J]. Sisli Etfal Hastan Tip Bul, 2020, 54(3):271-280.
|
[6] |
李玉秀,朱惠娟. 协和内分泌疾病诊疗常规[M]. 北京:中国协和医科大学出版社,2021: 332-337.
|
[7] |
Lenders JWM, Langton K, Langenhuijsen JF, et al. Pheochromocytoma and Pregnancy[J]. Endocrinol Metab Clin North Am, 2019, 48(3):605-617.
|
[8] |
孙淑娟.内分泌系统疾病治疗药物处方集[M].北京:人民卫生出版社,2018: 87-93.
|
[9] |
Bancos I, Atkinson E, Eng C, et al. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature[J]. Lancet Diabetes Endocrinol, 2021,9(1): 13-21.
|
[10] |
Johnson Clark T..约翰·霍普金斯妇产科手册[M].张岩,孙笑,主译. 北京:人民卫生出版社,2020: 204-205.
|
[11] |
Gruber LM, Young WF Jr, Bancos I. Pheochromocytoma and Paraganglioma in Pregnancy: A New Era [J]. Curr Cardiol Rep, 2021,23(6):60.
|
[12] |
徐丛剑,华克范勤. 实用妇产科学[M].4版. 北京:人民卫生出版社,2017: 229-230.
|
[13] |
Clifton-Bligh RJ. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy [J]. Rev Endocr Metab Disord, 2023, 24(1):49-56.
|
[14] |
Araujo-Castro M, Nattero Chavez L, Martínez Lorca A, et al. Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases [J]. Clin Exp Med, 2022,22,3:359-370.
|
[15] |
刘庆香,周伟燕,张传宝.儿茶盼胺及其代谢物的检测现状及标准化期望[J].中华检验医学杂志,2020,43(3):322-327.
|
[16] |
dLenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline [J]. J Clin Endocrinol Metab, 2014,99(6):1915-1942.
|
[17] |
Eisenhofer G,Peitzsch M,Kaden D,et al. Reference intervals for LCMS/MS measurements of plasma free, urinary free and urinary acidhydrolyzed deconjugated normetane phrine, metanephrine and methoxytyramine[J].Clin Chim Acta, 2019,490:46-54.
|
[18] |
Misasi G, Pancetti F, Giannini A, et al. Pheochromocytoma diagnosed during pregnancy: a case report [J].Gynecol Endocrinol,2020,36(7): 650-653.
|
[19] |
Langton K, Tufton N, Akker S, et al. Pregnancy and phaeochromocytoma/paraganglioma: clinical clues affecting diagnosis and outcome-a systematic review [J]. BJOG, 2021,128(8): 1264-1272.
|
[20] |
Pacak K, Taieb D. Phaeochromocytoma and pregnancy: looking towards better outcomes, less fear, and valuable recommendations [J].Lancet Diabetes Endocrinol, 2021, 9(1):2-3.
|
[21] |
Negro A, Verzicco I, Tedeschi S, et al. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency [J]. Blood Press, 2021, 30(5):322-326.
|
[22] |
彭光彩,曾淑梅,王夙斐,等. 妊娠期高血压危象合并肾上腺疾病的临床诊治分析[J]. 中华内分泌外科杂志,2022,16(1):119-122.
|